Because of AML’s aggressive nature, it traditionally requires aggressive—and immediate—treatment that involves intensive, high-dose chemotherapy and many weeks in the hospital. For older patients, however, such grueling treatment isn’t always promising, and many are mistakenly advised that their time and options are limited.

Four weeks after her 33rd birthday, Crystal found a lump in her breast. When she told a good friend and co-worker — whose mother happened to be in treatment for metastatic breast cancer — the friend told her, “Don’t mess around.”

I was told the tumor was inoperable and I had two years to live if I received chemotherapy and radiation. Just two years.

We have heard lots of information lately about talcum powder use and the risk of ovarian cancer. Let’s step back and look at the facts.

“Initially, ovarian cancer, melanoma, and some sarcomas are the three main targets,” says Dr. Koya, “but the clinical trial is open for patients with other cancers who meet the eligibility requirements."